Bruton's Tyrosine Kinase Inhibition Promotes Myelin Repair
Elodie Martin1, Marie-Stéphane Aigrot1, Roland Grenningloh2
1Sorbonne Université, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière, GH Pitié-Salpêtrière, F-75013 Paris, France.
Background:
Microglia are the resident macrophages of the central nervous system (CNS). In multiple sclerosis (MS) and related experimental models, microglia have either a pro-inflammatory or a pro-regenerative/pro-remyelinating function. Inhibition of Bruton's tyrosine kinase (BTK), a member of the Tec family of kinases, has been shown to block differentiation of pro-inflammatory macrophages in response to granulocyte-macrophage colony-stimulating factor in vitro. However, the role of BTK in the CNS is unknown.
Methods:
Our aim was to investigate the effect of BTK inhibition on myelin repair in ex vivo and in vivo experimental models of demyelination and remyelination. The remyelination effect of a BTK inhibitor (BTKi; BTKi-1) was then investigated in LPC-induced demyelinated cerebellar organotypic slice cultures and metronidazole-induced demyelinated Xenopus MBP-GFP-NTR transgenic tadpoles.
Results:
Cellular detection of BTK and its activated form BTK-phospho-Y223 (p-BTK) was determined by immunohistochemistry in organotypic cerebellar slice cultures, before and after lysophosphatidylcholine (LPC)-induced demyelination. A low BTK signal detected by immunolabeling under normal conditions in cerebellar slices was in sharp contrast to an 8.5-fold increase in the number of BTK-positive cells observed in LPC-demyelinated slice cultures. Under both conditions, approximately 75% of cells expressing BTK and p-BTK were microglia and 25% were astrocytes. Compared with spontaneous recovery, treatment of demyelinated slice cultures and MTZ-demyelinated transgenic tadpoles with BTKi resulted in at least a 1.7-fold improvement of remyelination.
Conclusion:
Our data demonstrate that BTK inhibition is a promising therapeutic strategy for myelin repair.
Insights
Inhibition of Bruton's tyrosine kinase (BTK) promotes myelin repair in the central nervous system. Targeting BTK in experimental models significantly improved remyelination, suggesting a new therapeutic strategy for demyelinating diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the CNS immune cells, play dual roles in neuroinflammation and repair.
- Bruton's tyrosine kinase (BTK) regulates macrophage differentiation but its CNS role is unclear.
- Multiple Sclerosis (MS) involves demyelination and impaired myelin repair.
Purpose of the Study:
- To investigate the role of BTK in central nervous system (CNS) myelin repair.
- To evaluate the efficacy of BTK inhibition in experimental models of demyelination and remyelination.
Main Methods:
- Assessed BTK expression in organotypic cerebellar slice cultures before and after lysophosphatidylcholine (LPC)-induced demyelination.
- Utilized immunohistochemistry to detect BTK and its activated form (p-BTK).
- Investigated the effect of a BTK inhibitor (BTKi) on remyelination in LPC-demyelinated slice cultures and metronidazole-induced demyelinated Xenopus tadpoles.
Main Results:
- BTK expression significantly increased in microglia and astrocytes following demyelination.
- BTK inhibition with BTKi enhanced myelin repair compared to spontaneous recovery.
- A 1.7-fold improvement in remyelination was observed in both slice cultures and tadpole models.
Conclusions:
- BTK is upregulated in microglia and astrocytes during CNS demyelination.
- Inhibiting BTK promotes myelin repair.
- BTK inhibition represents a promising therapeutic approach for demyelinating conditions.
More Related Videos
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...


